O53: Two years of clinical long read sequencing: Yes we can phase that – and yes, it is reimbursable
Abstract
The field of genomics has been defined by rapid growth and technological developments, transforming clinical genetic testing. However, the implementation of new technology into clinical testing is challenging for laboratories, given frequent updates to sequencing equipment resulting in capital expenditures coupled with the costs and time associated with method development and validation. Further, reimbursement in the United States healthcare system for new tests without established billing codes is difficult to predict.
Fields of Study & Subjects
Genomics and Rare Diseases
Genomics and Phylogenetic Studies
Prenatal Screening and Diagnostics
Publication details
- Journal / source
- Genetics in Medicine Open
- Volume
- 4
- Pages
- 104344–104344
- Publication date
- 1 January 2026
- Language
- EN